Dendritic cells and their potential therapeutic role in haematological malignancy.

about

Dendritic cells from patients with chronic myeloid leukemia: functional and phenotypic features.

P2860

Q36194635-C7A00C5F-A5C4-4369-A42C-538BFACEAE9D

P2860

Dendritic cells and their potential therapeutic role in haematological malignancy.

Item

http://www.wikidata.org/entity/Q35614625

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

2003年论文

@zh

2003年论文

@zh-cn

name

Dendritic cells and their potential therapeutic role in haematological malignancy.

@ast

Dendritic cells and their potential therapeutic role in haematological malignancy.

@en

type

Item

label

Dendritic cells and their potential therapeutic role in haematological malignancy.

@ast

Dendritic cells and their potential therapeutic role in haematological malignancy.

@en

prefLabel

Dendritic cells and their potential therapeutic role in haematological malignancy.

@ast

Dendritic cells and their potential therapeutic role in haematological malignancy.

@en

P1476

Dendritic cells and their potential therapeutic role in haematological malignancy.

@en

P2093

Goddard RV

http://www.w3.org/2001/XMLSchema#string

Kaminski ER

http://www.w3.org/2001/XMLSchema#string

Prentice AG

http://www.w3.org/2001/XMLSchema#string

P2860

Dendritic cells and the control of immunity

Generation in vitro of B-cell chronic lymphocytic leukaemia-proliferative and specific HLA class-II-restricted cytotoxic T-cell responses using autologous dendritic cells pulsed with tumour cell lysate

Dendritic cells derived from multiple myeloma patients efficiently internalize different classes of myeloma protein.

Dendritic cell vaccines for cancer immunotherapy.

Why are dendritic cells central to cancer immunotherapy?

Dendritic cells: development, function and potential use for cancer immunotherapy.

Dendritic cells: expansion and differentiation with hematopoietic growth factors.

T cells from the tumor microenvironment of patients with progressive myeloma can generate strong, tumor-specific cytolytic responses to autologous, tumor-loaded dendritic cells.

Dendritic cells and immunotherapy for malignant disease.

Dendritic cells as a tool to induce anergic and regulatory T cells.

P304

1657-1666

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1080/1042819031000090219

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

14692516

http://www.w3.org/2001/XMLSchema#string

Dendritic cells and their potential therapeutic role in haematological malignancy.

about

P2860

P2860

Dendritic cells and their potential therapeutic role in haematological malignancy.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698